Uridine triphosphate (UTP) and uridine diphosphate (UDP) are present in platelets, probably linked to storage organelles. In several animal species, UTP is a powerful constrictor of cerebral arteries, with no detectable dilatory component, which was confirmed in the present study. When testing the vasomotor effects of UTP and UDP in precontracted isolated segments of human pial arteries it was found that these nucleotides were powerful, transient dilators in the concentration range 10–7–10–5 Min the majority of vessels studied. At higher doses a contractile response supervened. Uridine monophosphate and uridine were without effect. Removal of the vessel endothelium mechanically or by perfusion with Triton abolished the dilatory response, and now the contraction appeared already at 3 × 10–6 M The present findings add UTP and UDP among the group of endothelium-linked biogenic vasodilators. This may be of pathophysiological importance in the maintenance of an adequate brain circulation in disorders involving platelet dysfunction.
SUMMARYThe effect of a slight reduction of extracellular magnesium on the tone of precontracted small human pial arteries and the dependence of the response on the functional integrity of the vascular endothelium was investigated in vitro. A decrease in extracellular magnesium from 1-2 to 0-8 mm resulted in sustained relaxation when the endothelium was intact. When the endothelium was disrupted, the same reduction resulted in an elevation of tone. These results suggest that small changes in extracellular magnesium modulate human cerebro-arterial tone through an endotheliumderived relaxing factor rather than by altering smooth muscle tone directly.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.